Next Article in Journal
Malnutrition and Gastrointestinal and Respiratory Infections in Children: A Public Health Problem
Next Article in Special Issue
Improving Public Health Through Access to and Utilization of Medication Assisted Treatment
Previous Article in Journal / Special Issue
The Dynamics of Norovirus Outbreak Epidemics: Recent Insights
Article Menu

Export Article

Open AccessArticle
Int. J. Environ. Res. Public Health 2011, 8(4), 1150-1173; doi:10.3390/ijerph8041150

The Public Health Impact of Coccidioidomycosis in Arizona and California

Global Health Sciences, University of California, San Francisco (UCSF),1200 Beale St., #1200, San Francisco, CA 94105, USA
Arizona Department of Health Services, 150 N 18th Ave., Ste. 140, Phoenix, AZ 85007, USA
Infectious Diseases Branch, Division of Communicable Disease Control (DCDC), Center for Infectious Diseases (CID), California Department of Public Health, P.O. Box 997377, Sacramento, CA 95899, USA
Valley Fever Center for Excellence, College of Medicine, The University of Arizona, 1656 E. Mabel Street, Tucson, AZ 85724, USA
Author to whom correspondence should be addressed.
Received: 24 February 2011 / Revised: 12 April 2011 / Accepted: 13 April 2011 / Published: 15 April 2011
(This article belongs to the Special Issue Recent Advances in Public Health)
View Full-Text   |   Download PDF [662 KB, 19 June 2014; original version 19 June 2014]   |  


The numbers of reported cases of coccidioidomycosis in Arizona and California have risen dramatically over the past decade, with a 97.8% and 91.1% increase in incidence rates from 2001 to 2006 in the two states, respectively. Of those cases with reported race/ethnicity information, Black/African Americans in Arizona and Hispanics and African/Americans in California experienced a disproportionately higher frequency of disease compared to other racial/ethnic groups. Lack of early diagnosis continues to be a problem, particularly in suspect community-acquired pneumonia, underscoring the need for more rapid and sensitive tests. Similarly, the inability of currently available therapeutics to reduce the duration and morbidity of this disease underscores the need for improved therapeutics and a preventive vaccine.
Keywords: coccidioidomycosis; community-acquired pneumonia; diagnostics; azoles; vaccine coccidioidomycosis; community-acquired pneumonia; diagnostics; azoles; vaccine
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Hector, R.F.; Rutherford, G.W.; Tsang, C.A.; Erhart, L.M.; McCotter, O.; Anderson, S.M.; Komatsu, K.; Tabnak, F.; Vugia, D.J.; Yang, Y.; Galgiani, J.N. The Public Health Impact of Coccidioidomycosis in Arizona and California. Int. J. Environ. Res. Public Health 2011, 8, 1150-1173.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Environ. Res. Public Health EISSN 1660-4601 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top